Ryan Halsted
Stock Analyst at RBC Capital
(3.82)
# 1,952
Out of 5,044 analysts
120
Total ratings
57.6%
Success rate
9.2%
Average return
Main Sectors:
Stocks Rated by Ryan Halsted
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CAH Cardinal Health | Reiterated: Buy | $276 | $237.57 | +16.18% | 2 | Oct 6, 2026 | |
| COR Cencora | Reiterated: Hold | $330 | $323.85 | +1.90% | 3 | Oct 6, 2026 | |
| CRL Charles River Laboratories International | Reiterated: Buy | $322 | $301.79 | +6.70% | 8 | Oct 6, 2026 | |
| DOCS Doximity | Reiterated: Buy | $28 | $30.50 | -8.20% | 11 | Oct 6, 2026 | |
| EVH Evolent Health | Reiterated: Hold | $3 | $4.04 | -25.74% | 7 | Oct 6, 2026 | |
| HCSG Healthcare Services Group | Reiterated: Hold | $24 | $20.59 | +16.56% | 6 | Oct 6, 2026 | |
| HQY HealthEquity | Reiterated: Buy | $108 | $92.61 | +16.62% | 5 | Oct 6, 2026 | |
| ICLR ICON Public Limited Company | Reiterated: Buy | $185 | $164.17 | +12.69% | 6 | Oct 6, 2026 | |
| IQV IQVIA Holdings | Reiterated: Buy | $319 | $259.88 | +22.75% | 8 | Oct 6, 2026 | |
| MCK McKesson | Reiterated: Hold | $845 | $938.84 | -10.00% | 3 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 | $36.26 | +26.86% | 8 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $692 | $612.05 | +13.06% | 7 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 | $10.81 | +75.76% | 7 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 | $20.85 | +48.68% | 9 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $18.06 | +32.89% | 11 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 | $26.68 | +64.92% | 10 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $10.12 | n/a | 4 | Jan 12, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $35.24 | n/a | 1 | Oct 6, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $76.91 | n/a | 1 | Sep 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $22 | $171.80 | n/a | 3 | May 12, 2016 |
Cardinal Health
Oct 6, 2026
Reiterated: Buy
Price Target: $276
Current: $237.57
Upside: +16.18%
Cencora
Oct 6, 2026
Reiterated: Hold
Price Target: $330
Current: $323.85
Upside: +1.90%
Charles River Laboratories International
Oct 6, 2026
Reiterated: Buy
Price Target: $322
Current: $301.79
Upside: +6.70%
Doximity
Oct 6, 2026
Reiterated: Buy
Price Target: $28
Current: $30.50
Upside: -8.20%
Evolent Health
Oct 6, 2026
Reiterated: Hold
Price Target: $3
Current: $4.04
Upside: -25.74%
Healthcare Services Group
Oct 6, 2026
Reiterated: Hold
Price Target: $24
Current: $20.59
Upside: +16.56%
HealthEquity
Oct 6, 2026
Reiterated: Buy
Price Target: $108
Current: $92.61
Upside: +16.62%
ICON Public Limited Company
Oct 6, 2026
Reiterated: Buy
Price Target: $185
Current: $164.17
Upside: +12.69%
IQVIA Holdings
Oct 6, 2026
Reiterated: Buy
Price Target: $319
Current: $259.88
Upside: +22.75%
McKesson
Oct 6, 2026
Reiterated: Hold
Price Target: $845
Current: $938.84
Upside: -10.00%
Oct 6, 2026
Reiterated: Buy
Price Target: $46
Current: $36.26
Upside: +26.86%
Oct 6, 2026
Reiterated: Buy
Price Target: $692
Current: $612.05
Upside: +13.06%
Oct 6, 2026
Reiterated: Buy
Price Target: $19
Current: $10.81
Upside: +75.76%
Oct 6, 2026
Reiterated: Buy
Price Target: $31
Current: $20.85
Upside: +48.68%
Oct 6, 2026
Reiterated: Buy
Price Target: $24
Current: $18.06
Upside: +32.89%
Oct 6, 2026
Reiterated: Buy
Price Target: $44
Current: $26.68
Upside: +64.92%
Jan 12, 2017
Upgraded: Buy
Price Target: n/a
Current: $10.12
Upside: n/a
Oct 6, 2016
Reiterated: Hold
Price Target: n/a
Current: $35.24
Upside: n/a
Sep 9, 2016
Reiterated: Hold
Price Target: n/a
Current: $76.91
Upside: n/a
May 12, 2016
Reiterated: Hold
Price Target: $22
Current: $171.80
Upside: n/a